Beta-Secretase Inhibitor II
-
Catalog number
7502-1
-
Price
Please ask
-
Size
1 mg
-
-
Description
A potent, cell permeable and reversible inhibitor of β-secretase that corresponds to the β-secretase cleavage site (VNL-DA) of the Swedish mutant Amyloid Precursor Protein (APP). Inhibits the formation of both Aβtotal (IC₅₀ = 700 nM) and Aβ1-42 (IC₅₀ = 2.5 µM) in CHO cells stably transfected with wild-type APP751.
-
Structure Available
No
-
Peptide sequence
Z-Val-Leu-Leu--CHO
-
Salt Form
No
-
Molecular Formula
C₂₅H₃₉N₃O₅
-
Molecular Weight
461.6
-
Cell Permeable
Yes
-
Purity
≥95% by HPLC
-
Solubilities
DMSO
-
Handling
Protect from air and moisture
-
Tag Line
A beta-secretase inhibitor
-
Storage Condition
-20°C
-
Shipping Condition
gel pack
-
Shelf Life
12 months
-
PubChem CID
10253763
-
-
SMILES
CC(C)CC(C=O)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)OCC1=CC=CC=C1
-
InChi
239-200(315)150(93-258)251-190(305)143(82-112-90-215-95-219-112)248-203
-
InChi Key
YHUAFMGVVANYBT-FKBYEOEOSA-N
-
-
MSDS Available
Yes
-
Additional description
Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
Product images
Similar products